Chase AIBulk Dataset ExportPricingFAQsBlog
Display currency
Loading news…

Abcam

Cambridge, Cambridgeshire, United Kingdom

Abcam helps researches with breakthroughs in areas such as cancer, neurological disorders, infectious diseases, and metabolic disorders.

Abcam on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.

Abcam was acquired by Danaher in 2023 for $5.7B.
Total Funding
$336.41M
Funding Rounds
3
Last Funding
Acquisitions
8
Investments
1
Monthly Visits
Contacts
919
Patents
42
6 trademarks

About Abcam

Funding & Financials

Total funding
Funding rounds
Last funding
Last funding type
Last funding date
Funding status
Total equity funding
Revenue range

Web Traffic

Monthly visits
Global traffic rank
6-mo avg visits
Visit duration (s)
Pages / visit
Bounce rate
Rank change (mo)

Technology & IP

Active technologies
96
Mobile apps
2
Downloads (30d)
21
Active products
30
Patents granted
42
Trademarks
6
Top patent class
Organic Chemistry
IT spend
$38.8M

Investor Activity

Investments
1
Portfolio orgs
1

Company Info

Org types
company, investor
HQ
Cambridge, Cambridgeshire, United Kingdom

Signals & Scores

Trend (7d)
0
Trend (30d)
-0.3
Trend (90d)
-0.1

Abcam Funding Rounds

3 results
Upgrade to Pro to view this datasetUpgrade
Organization NameFunding TypeLead Investor NamesInvestor NamesFunding StageOrg IndustriesOrg Hq CityOrg Hq CountryOrg DescriptionOrg Number Of EmployeesOrg Website
1–3 of 3Show
Page 1 / 1

Abcam Investments

Loading columns…
0 of 0Show
Page 1 / 1

Abcam Acquisitions

8 results
Acquiree NameAcquirer NameAcquisition TypeAcquisition TermsAcquiree IndustriesAcquiree Hq CityAcquiree Hq CountryAcquiree DescriptionAcquiree Number Of EmployeesAcquirer IndustriesAcquirer Hq CountryAcquirer Number Of EmployeesAcquirer Ipo StatusAcquiree Website
Biovision$340M2021-08-02AbcamAcquisitionCashBiotechnologyHealth CareMilpitasUnited StatesBioVision is a privately held Life Science company headquart1999-01-0151-100BiotechnologyLife ScienceUnited Kingdom8www.biovision.com
Marker Gene Technologies2020-03-04AbcamAcquisitionBiotechnologyLife ScienceEugeneUnited StatesMarker Gene Technologies develops innovative new products fo1993-01-01BiotechnologyLife ScienceUnited Kingdom8www.markergene.com/
Expedeon$132.49M2019-11-11AbcamAcquisitionCashBiotechnologyLife ScienceMedicalCambridgeUnited StatesExpedeon is an expert in cutting-edge innovative reagents an2002-01-011001-5000BiotechnologyLife ScienceUnited Kingdom8www.expedeon.com
Calico Biolabs2019-01-28AbcamAcquisitionBiotechnologyInformation TechnologyPleasantonUnited StatesCalico Biolabs partner with diagnostic and pharmaceutical co2011-01-01BiotechnologyLife ScienceUnited Kingdom8www.calicobio.com/
AxioMx$45M2015-11-11AbcamAcquisitionCashBiotechnologyHealth DiagnosticsMarketplaceBranfordUnited StatesAxioMx offers antibody discovery and development services foBiotechnologyLife ScienceUnited Kingdom8axiomxinc.com
1–5 of 8Show
Page 1 / 2

Abcam Key People

SVP, Supply Chain & Manufacturing
Chief Financial Officer
Vice President Research and Innovation
RPA Analyst
Director of Computational R&D
Director Of Business Development
919
professional contacts at Abcam
Contact execs at Abcam

Explore 200,000+ acquisitions — free

Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.

Explore all acquisitions
Bulk Dataset Export

Need the data in bulk? Buy the entire dataset.

5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools

Delivered as CSV, JSON or Parquet — at startup-friendly pricing.

See bulk export

Recent News related to Abcam

Loading news…

FAQs about Abcam

People who checked this page also checked these

Browse the full Acquirezy directory.